News Release


Kyorin Pharmaceutical announces a sales rights transfer agreement for anti-bacterial agent with GaldermaK.K

March 19, 2002

Sales rights transfer agreement in Japan for the anti-bacterial agent PEKIRON® Cream

Kyorin Pharmaceutical Co., Ltd. (President, Ikuo Ogihara, Head office: Chiyoda-ku, Tokyo) announces a sales rights transfer agreeme nt in Japan for the Morpholine derivatives anti-bacterial agent, PEKIRON® Cream (amorolfine,INN) with Galderma K.K (an incorporated Japanese company and a subsidiary of the joint venture between Neslé and L'Oréal. General manager, Eiichi Kitano, Japan office: Chiyoda-ku, Tokyo).

Get Adobe Acrobat Reader

Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.